Application of Bone Morphogenetic Proteins on Solid Implants

  • J. A. Mollenhauer
  • K. D. Jandt
  • P. Hortschansky
Conference paper
Part of the Ceramics in Orthopaedics book series (CIO)


Bone Morphogenetic Proteins (BMP) induce and propagate skeletal wound healing. They enable osteoinductive mechanisms. Applied in combination with osteoconductive solid implant materials, BMP might accelerate and enhance bone regeneration even in individuals with compromised bone metabolism, such as osteoporotic or elderly patients. Presently, soluble BMP released from rapidly degrading carriers such as collagen is favored. Here we present structural and functional aspects of bioactivity from small quantities of implant surface-fixed BMP, potentially resulting in a more controlled topical action. Solid implants such improved may prevent untoward effects from overdosing and may exhibit better storage properties than present preparations of BMP.


Bone Morphogenetic Protein Ti6Al4V Alloy Chitosan Scaffold Bone Morphogenetic Protein Receptor Enhance Bone Regeneration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger DC, Kuettner KE.: Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1) (2002) Biochim Biophys Acta. 1588(2):126–34.Google Scholar
  2. 2.
    Clement JH, Raida M, Sanger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A, Hoffken K, Wolft S, Harris AL. (2005) Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol. 2:401–7.Google Scholar
  3. 3.
    Flechtenmacher J, Huch K, Thonar EJ-MA, Mollenhauer J, Davies SJ, Schmid TM, Puhl W, Sampath K, Aydelotte MB, Kuettner KE (1996) Recombinant human osteogenicprotein 1 (rHuOP-1) is a potent stimulator of synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 39:1896–1904.PubMedGoogle Scholar
  4. 4.
    Gründer T, Gaissmaier C, Fritz J, Stoop R, Hortschansky P, Mollenhauer J, Aicher WK. (2004) Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 7:559–67.CrossRefGoogle Scholar
  5. 5.
    Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, et al. (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts. J Cell Biol 127:1755–66.PubMedCrossRefGoogle Scholar
  6. 6.
    Kessler S, Mayr-Wohlfahrt U, Ignatius A, Puhl W, Claes L, Günther KP (2003) The impact of bone morphogenetic protein-1 (BMP-2), vascular endothelial growth factor (VEGF) und basischem Fibroblastenwachstumsfaktor (b-FGF) auf Osteointegration, Degradation und biomechanische Eigenschaften eines synthetischen Knochenersatzstoffes. Z Orthopädie 141: 472–481.CrossRefGoogle Scholar
  7. 7.
    Kirsch T, Nickel J, Sebald W. (2000) BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19: 3314–3324.PubMedCrossRefGoogle Scholar
  8. 8.
    Lichtinger TK, Müller RT, Schürmann N, Oldenburg M, Wiemann M, Chatzinikolaidou M, Rumpf HM, Jennissen HP (2001) Osseointegration of titanium implants by addition of recombinant Bone Morphogenetic Protein 2 (rhBMP-2). Mat.-wiss. u. Werkstofftech. 32, 937–941.CrossRefGoogle Scholar
  9. 9.
    Manjubala I, Scheler S, Bossert J, Jandt KD (2006) Mineralisation of chitosan scaffolds with nano-apatite formation by double diffusion technique. Acta Biomaterialia 2:75–84.PubMedCrossRefGoogle Scholar
  10. 10.
    McGee MA, Findlay DM, Howie DW, Carbone A, Ward P, Stamenkov R, Page TT, Bruce WJ, Wildenauer CI, Toth C (2004) The use of OP-1 in femoral impaction grafting in a sheep model. J Orthop Res 22:1008–1015.PubMedCrossRefGoogle Scholar
  11. 11.
    Murakamia N, Saitoa N, Takahashia J, Otaa H, Horiuchia H, Nawataa M, Okadab T, Nozakic K, Takaokad K (2003) Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 24:2153–2159.CrossRefGoogle Scholar
  12. 12.
    Sachse A, Wagner A, Keller M, Wagner O, Wetzel WD, Layher F, Venbrocks RA, Hortschansky P, Pietraszczyk M, Wiederanders B, Hempel HJ, Bossert J, Horn J, Schmuck K, Mollenhauer J (2005) Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 37:699–710PubMedCrossRefGoogle Scholar
  13. 13.
    Schmoekel H., Schense J.C, Weber F.E., Graetz K.W., Gnaegi D., Mueller R., Hubbell J.A. (2004) Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res 22:376–381.PubMedCrossRefGoogle Scholar
  14. 14.
    Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. (2004) Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 22:58–65.PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag, Darmstadt 2006

Authors and Affiliations

  • J. A. Mollenhauer
  • K. D. Jandt
  • P. Hortschansky

There are no affiliations available

Personalised recommendations